Estimated intervention effects on total sickness absence, by presence of the identified supporting factors
| Phase I | Phase I + II + III | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n (groups) | Estimated effect1 (β) | 95% CI | p-value | Type 3 test p-value | n (groups) | Estimated effect1 (β) | 95% CI | p-value | Type 3 test p-value | ||
| Presence of supporting conditions | |||||||||||
| None | 2 | −0.35 | (−2.1–1.4) | 0.7 | 0.001 | 2 | −0.24 | (−1.9–1.5) | 0.8 | <0.001 | |
| Some2 | 3 | −1.7 | (−3.2– −0.14) | 0.03 | 4 | −1.3 | (−2.6–0.02) | 0.05 | |||
| All | 3 | −2.9 | (−4.4– −1.4) | <0.001 | 2 | −4.2 | (−5.9– −2.4) | <0.001 | |||
| Phase I | Phase I + II + III | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Estimated effect1 ( | 95% CI | Type 3 test | Estimated effect1 ( | 95% CI | Type 3 test | ||||||
| None | 2 | −0.35 | (−2.1–1.4) | 0.7 | 0.001 | 2 | −0.24 | (−1.9–1.5) | 0.8 | <0.001 | |
| Some2 | 3 | −1.7 | (−3.2– −0.14) | 0.03 | 4 | −1.3 | (−2.6–0.02) | 0.05 | |||
| All | 3 | −2.9 | (−4.4– −1.4) | <0.001 | 2 | −4.2 | (−5.9– −2.4) | <0.001 | |||
Note(s): 1Estimated difference (%) between pre- and post-intervention using mixed effect models
2One out of three for phase I, and two or three out of eight for phases I + II + III
CI = confidence interval